Clinical Trials Directory

Trials / Completed

CompletedNCT05866211

Lung Function in Post-COVID-19 Nursing Home Residents

Associated Factors for Impaired Lung Function in Post-COVID Nursing Home Residents

Status
Completed
Phase
Study type
Observational
Enrollment
184 (actual)
Sponsor
University of Vic - Central University of Catalonia · Academic / Other
Sex
All
Age
65 Years – 95 Years
Healthy volunteers
Not accepted

Summary

The coronavirus disease 2019 (COVID-19) took a toll in institutionalised older adults, who represent a vulnerable population in European countries. The aim of this study is to identify the predictive factors that worsens lung function in post-COVID nursing home (NH) residents. This is a multicenter case-control study in nursing homes of Osona (Catalonia), where individuals with worsened (cases) and normal (controls) lung function will be studied. The inclusion criteria are: female and male from 65 to 95 years old, preserved cognitive capacity and positive diagnosis of COVID-19 at least 3 months prior. We will assess sociodemographic variables, lung function \[spirometry\], fatigue \[Chalder Fatigue Scale\], frailty \[Clinical Frailty Scale\], and activities of daily living (ADL) \[modified Barthel index\].

Conditions

Interventions

TypeNameDescription
OTHERPrevious exposure to SARS-CoV-2This is an observational study in which no intervention will be applied.

Timeline

Start date
2022-04-25
Primary completion
2022-11-30
Completion
2024-01-30
First posted
2023-05-19
Last updated
2024-12-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05866211. Inclusion in this directory is not an endorsement.